Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 38
Filter
2.
Mucosal Immunol ; 9(5): 1303-16, 2016 09.
Article in English | MEDLINE | ID: mdl-26906404

ABSTRACT

Human rhinovirus (HRV) infections are major contributors to the healthcare burden associated with acute exacerbations of chronic airway disease, such as chronic obstructive pulmonary disease and asthma. Cellular responses to HRV are mediated through pattern recognition receptors that may in part signal from membrane microdomains. We previously found Toll-like receptor signaling is reduced, by targeting membrane microdomains with a specific liposomal phosphatidylserine species, 1-stearoyl-2-arachidonoyl-sn-glycero-3-phospho-L-serine (SAPS). Here we explored the ability of this approach to target a clinically important pathogen. We determined the biochemical and biophysical properties and stability of SAPS liposomes and studied their ability to modulate rhinovirus-induced inflammation, measured by cytokine production, and rhinovirus replication in both immortalized and normal primary bronchial epithelial cells. SAPS liposomes rapidly partitioned throughout the plasma membrane and internal cellular membranes of epithelial cells. Uptake of liposomes did not cause cell death, but was associated with markedly reduced inflammatory responses to rhinovirus, at the expense of only modest non-significant increases in viral replication, and without impairment of interferon receptor signaling. Thus using liposomes of phosphatidylserine to target membrane microdomains is a feasible mechanism for modulating rhinovirus-induced signaling, and potentially a prototypic new therapy for viral-mediated inflammation.


Subject(s)
Epithelial Cells/drug effects , Host-Pathogen Interactions/drug effects , Liposomes/pharmacology , Phosphatidylserines/pharmacology , Respiratory Mucosa/drug effects , Rhinovirus/drug effects , Adaptor Proteins, Signal Transducing/deficiency , Adaptor Proteins, Signal Transducing/genetics , Adaptor Proteins, Signal Transducing/immunology , Adaptor Proteins, Vesicular Transport/deficiency , Adaptor Proteins, Vesicular Transport/genetics , Adaptor Proteins, Vesicular Transport/immunology , Cell Line , Chemokine CCL5/genetics , Chemokine CCL5/immunology , Chemokine CXCL10/genetics , Chemokine CXCL10/immunology , Epithelial Cells/immunology , Epithelial Cells/virology , Gene Expression Regulation/drug effects , Humans , Interferon-beta/genetics , Interferon-beta/immunology , Interleukin-8/genetics , Interleukin-8/immunology , Liposomes/chemical synthesis , Phosphatidylserines/chemistry , Phospholipid Ethers/chemistry , Phospholipid Ethers/pharmacology , Respiratory Mucosa/immunology , Respiratory Mucosa/virology , Rhinovirus/growth & development , Rhinovirus/immunology , Signal Transduction , Virus Replication/drug effects
3.
Thorax ; 70(4): 382-7, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25523307

ABSTRACT

We evaluated the prevalence and prognostic value of CT-pulmonary angiographic (CTPA) measures in 292 treatment naive patients with pulmonary arterial hypertension (PAH). Pulmonary artery calcification (13%) and thrombus (10%) were exclusively seen in PAH-congenital heart disease. Oesophageal dilation (46%) was most frequent in PAH-systemic sclerosis. Ground glass opacification (GGO) (41%), pericardial effusion (38%), lymphadenopathy (19%) and pleural effusion (11%) were common. On multivariate analysis, inferior vena caval area, the presence of pleural effusion and septal lines predicted outcome. In PAH, CTPA provides diagnostic and prognostic information. In addition, the presence of GGO on a CT performed for unexplained breathlessness should alert the physician to the possibility of PAH.


Subject(s)
Hypertension, Pulmonary/diagnostic imaging , Adult , Aged , Aortography/methods , Female , Heart Defects, Congenital/complications , Heart Defects, Congenital/diagnostic imaging , Hemodynamics/physiology , Humans , Hypertension, Pulmonary/etiology , Hypertension, Pulmonary/physiopathology , Kaplan-Meier Estimate , Male , Middle Aged , Prognosis , Pulmonary Artery/diagnostic imaging , Registries , Scleroderma, Systemic/complications , Scleroderma, Systemic/diagnostic imaging , Tomography, X-Ray Computed/methods
4.
Clin Exp Allergy ; 44(1): 20-8, 2014 Jan.
Article in English | MEDLINE | ID: mdl-24355017

ABSTRACT

Human rhinoviruses (HRV) have been linked to the development of childhood asthma and recurrent acute asthma exacerbations throughout life, and contribute considerably to the healthcare and economic burden of this disease. However, the ability of HRV infections to trigger exacerbations, and the link between allergic status and HRV responsiveness, remains incompletely understood. Whilst the receptors on human airway cells that detect and are utilized by most HRV group A and B, but not C serotypes are known, how endosomal pattern recognition receptors (PRRs) detect HRV replication products that are generated within the cytoplasm remains somewhat of an enigma. In this article, we explore a role for autophagy, a cellular homeostatic process that allows the cell to encapsulate its own cytosolic constituents, as the crucial mechanism controlling this process and regulating the innate immune response of airway epithelial cells to viral infection. We will also briefly describe some of the recent insights into the immune responses of the airway to HRV, focusing on neutrophilic inflammation that is a potentially unwanted feature of the acute response to viral infection, and the roles of IL-1 and Pellinos in the regulation of responses to HRV.


Subject(s)
Asthma/complications , Asthma/virology , Picornaviridae Infections/complications , Picornaviridae Infections/virology , Rhinovirus/physiology , Asthma/diagnosis , Asthma/immunology , Autophagy , Bronchiolitis, Viral/complications , Bronchiolitis, Viral/diagnosis , Bronchiolitis, Viral/immunology , Bronchiolitis, Viral/metabolism , Humans , Immunity, Innate , Picornaviridae Infections/diagnosis , Picornaviridae Infections/immunology , Receptors, Pattern Recognition/metabolism , Respiratory Mucosa/immunology , Respiratory Mucosa/metabolism , Respiratory Mucosa/virology , Rhinovirus/classification , Serotyping , Virus Internalization
5.
Clin Exp Dermatol ; 38(8): 874-7, 2013 Dec.
Article in English | MEDLINE | ID: mdl-23889084

ABSTRACT

We report a man with lifelong urticaria, night sweats, arthralgia and lethargy. He had high levels of inflammatory markers and serum amyloid A, but no identifiable mutation in exon 3 of the NLRP3 (NOD-like receptor family, pyrin domain-1 containing 3) gene, and no relevant family history. We found marked production of functional interleukin (IL)-1 by the patient's monocytes at baseline and after stimulation with lipopolysaccharide. The patient made an immediate response to treatment with an IL-1ß receptor antagonist. We propose that this patient has Muckle-Wells syndrome without deafness, occurring de novo. Functional screening for IL-1 production could aid diagnosis in future similar cases.


Subject(s)
Antirheumatic Agents/therapeutic use , Carrier Proteins/genetics , Cryopyrin-Associated Periodic Syndromes/drug therapy , Interleukin 1 Receptor Antagonist Protein/therapeutic use , Interleukin-1beta/metabolism , Monocytes/metabolism , Cryopyrin-Associated Periodic Syndromes/genetics , Cryopyrin-Associated Periodic Syndromes/metabolism , Exons/genetics , Humans , Male , Middle Aged , NLR Family, Pyrin Domain-Containing 3 Protein , Treatment Outcome
6.
Eur J Clin Microbiol Infect Dis ; 32(7): 883-9, 2013 Jul.
Article in English | MEDLINE | ID: mdl-23388830

ABSTRACT

Catheter-related blood stream infection (CR-BSI) in patients with pulmonary hypertension (PH) receiving intravenous iloprost via an indwelling central line has previously not been fully described. Recent studies have suggested a link between the pH of prostanoid infusions and the rate and nature of CR-BSI. We have investigated CR-BSI in patients receiving intravenous iloprost at our unit. Databases and hospital records were interrogated for all patients receiving intravenous iloprost between September 2007 and June 2012. Fifty-nine patients received intravenous iloprost via an indwelling central catheter with a total of 23,072 treatment days. There were 15 episodes of CR-BSI, identified using a systematic screening protocol, involving 11 patients giving an overall CR-BSI rate of 0.65/1,000 treatment days. CR-BSI rate for Gram-positive organisms was 0.26/1,000 treatment-days and for Gram-negative organisms was 0.39/1,000 treatment-days. The pH of iloprost in typical dosing regimens was comparable to the pH used in standard-diluent treprostinil and dissimilar to alkaline epoprostenol infusions. The proportion of Gram-negative CR-BSI was similar to that reported for standard-diluent treprostinil. CRP was normal on admission in 33 % of cases of confirmed CR-BSI and remained normal in 13 % of cases. CR-BSI rates with intravenous iloprost are comparable to those observed for other prostanoids. The high proportion of Gram-negative organisms observed and the neutral pH of iloprost infusions support the previously hypothesised link between pH and antimicrobial activity. Although usually elevated during a CR-BSI, CRP may be normal in early infection and a normal result cannot completely exclude infection.


Subject(s)
Bacteremia/chemically induced , Catheter-Related Infections/chemically induced , Central Venous Catheters/adverse effects , Hypertension, Pulmonary/drug therapy , Iloprost/adverse effects , Iloprost/therapeutic use , Administration, Intravenous , Adult , Aged , Female , Gram-Negative Bacteria/isolation & purification , Gram-Positive Bacteria/isolation & purification , Humans , Male , Middle Aged
7.
Eur Respir J ; 39(4): 945-55, 2012 Apr.
Article in English | MEDLINE | ID: mdl-21885399

ABSTRACT

Pulmonary hypertension (PH) is a heterogeneous condition. To date, no registry data exists reflecting the spectrum of disease across the five diagnostic groups encountered in a specialist referral centre. Data was retrieved for consecutive, treatment-naïve cases diagnosed between 2001 and 2010 using a catheter-based approach. 1,344 patients were enrolled, with a mean follow-up of 2.9 yrs. The 3-yr survival was 68% for pulmonary arterial hypertension (PAH), 73% for PH associated with left heart disease, 44% for PH associated with lung disease (PH-lung), 71% for chronic thromboembolic PH (CTEPH) and 59% for miscellaneous PH. Compared with PAH, survival was inferior in PH-lung and superior in CTEPH (p<0.05). Multivariate analysis demonstrated that diagnostic group independently predicted survival. Within PAH, Eisenmenger's survival was superior to idiopathic PAH, which was superior to PAH associated with systemic sclerosis (p<0.005). Within PH-lung, 3-yr survival in sleep disorders/alveolar hypoventilation (90%) was superior to PH-lung with chronic obstructive pulmonary disease (41%) and interstitial lung disease (16%) (p<0.05). In CTEPH, long-term survival was best in patients with surgically accessible disease undergoing pulmonary endarterectomy. In this large registry of consecutive, treatment-naïve patients identified at a specialist PH centre, outcomes and characteristics differed between and within PH groups. The current system of classification of PH has prognostic value even when adjusted for age and disease severity, emphasising the importance of systematic evaluation and precise classification.


Subject(s)
Diagnosis-Related Groups/classification , Hypertension, Pulmonary/classification , Hypertension, Pulmonary/diagnosis , Referral and Consultation/statistics & numerical data , Registries/statistics & numerical data , Adult , Aged , Diagnosis-Related Groups/statistics & numerical data , Endarterectomy/mortality , Female , Follow-Up Studies , Heart Defects, Congenital/classification , Heart Defects, Congenital/diagnosis , Heart Defects, Congenital/mortality , Humans , Hypertension, Pulmonary/mortality , Hypertension, Pulmonary/surgery , Male , Middle Aged , Multivariate Analysis , Prognosis , Pulmonary Disease, Chronic Obstructive/classification , Pulmonary Disease, Chronic Obstructive/diagnosis , Pulmonary Disease, Chronic Obstructive/mortality , Pulmonary Disease, Chronic Obstructive/surgery , Severity of Illness Index , Sleep Wake Disorders/classification , Sleep Wake Disorders/diagnosis , Sleep Wake Disorders/mortality , Survival Analysis , Thromboembolism/classification , Thromboembolism/diagnosis , Thromboembolism/mortality
8.
Curr Mol Med ; 10(8): 727-40, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20937022

ABSTRACT

HIV-1 can establish both long lived and productive infection of macrophages (Mϕ) but circulating monocytes are less permissive to infection. Multiple studies have identified extensive changes to monocyte and Mϕ phenotype, differentiation or function. These include alterations in Toll-like receptor signaling and resultant changes to cytokine responses, specific defects in phagocytosis and microbial killing and modulation of apoptotic responses, all of which may perturb the important role of these cells in innate immunity. Interpretation of contradictory data however, is complicated by the use of different experimental models and many of the reported effects may be an indirect consequence of HIV 1 infection that result from exposure to viral products or from disruption of cellular and cytokine networks in the immune system, rather than the direct consequence of productive HIV 1 infection. Future research should focus on refining experimental models and on elucidating the physiological mechanisms of monocyte/ Mϕ dysfunction during HIV 1 infection.


Subject(s)
HIV Infections/immunology , HIV-1 , Immunity, Innate/immunology , Macrophages/immunology , Monocytes/immunology , Animals , Apoptosis , HIV Infections/virology , Humans , Models, Biological , Phagocytosis , Signal Transduction , Toll-Like Receptors/metabolism
9.
Am J Physiol Lung Cell Mol Physiol ; 299(2): L263-71, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20435687

ABSTRACT

Induction of effective inflammation in the lung in response to environmental and microbial stimuli is dependent on cooperative signaling between leukocytes and lung tissue cells. We explored how these inflammatory networks are modulated by diesel exhaust particles (DEP) using cocultures of human monocytes with epithelial cells. Cocultures, or monoculture controls, were treated with DEP in the presence or absence of LPS or flagellin. Production of cytokines was explored by Western blotting and ELISA; cell signaling was analyzed by Western blotting. Here, we show that responses of epithelial cells to DEP are amplified by the presence of monocytes. DEP amplified the responses of cellular cocultures to very low doses of TLR agonists. In addition, in the presence of DEP, the responses induced by LPS or flagellin were less amenable to antagonism by the physiological IL-1 antagonist, IL-1ra. This was paralleled by the uncoupling of IL-1 production and release from monocytes, potentially attributable to an ability of DEP to sequester or degrade extracellular ATP. These data describe a model of inflammation where DEP amplifies responses to low concentrations of microbial agonists and alters the nature of the inflammatory milieu induced by TLR agonists.


Subject(s)
Inflammation/immunology , Lung/immunology , Vehicle Emissions/toxicity , Adenosine Triphosphate/metabolism , Cell Line , Coculture Techniques , Cytokines/biosynthesis , Flagellin/pharmacology , Humans , Interleukin 1 Receptor Antagonist Protein/immunology , Interleukin-1/physiology , Interleukin-1beta/biosynthesis , Interleukin-8/biosynthesis , Lipopolysaccharides/pharmacology , Monocytes/immunology , Respiratory Mucosa/cytology , Signal Transduction/physiology , Toll-Like Receptors/agonists
10.
Clin Exp Immunol ; 157(2): 216-24, 2009 Aug.
Article in English | MEDLINE | ID: mdl-19604261

ABSTRACT

Recent developments in the study of host-pathogen interactions have fundamentally altered our understanding of the nature of Staphylococcus aureus infection, and previously held tenets regarding the role of the granulocyte are being cast aside. Novel mechanisms of pathogenesis are becoming evident, revealing the extent to which S. aureus can evade neutrophil responses successfully by resisting microbicides, surviving intracellularly and subverting cell death pathways. Developing a detailed understanding of these complex strategies is especially relevant in light of increasing staphylococcal virulence and antibiotic resistance, and the knowledge that dysfunctional neutrophil responses contribute materially to poor host outcomes. Unravelling the biology of these interactions is a challenging task, but one which may yield new strategies to address this, as yet, defiant organism.


Subject(s)
Skin/microbiology , Staphylococcal Infections/immunology , Staphylococcus aureus/physiology , Abscess/immunology , Cell Death , Host-Pathogen Interactions , Humans , Immunocompromised Host , Leukocyte Count , Neutrophils/immunology , Staphylococcal Infections/drug therapy , Staphylococcal Infections/microbiology , Virulence
11.
Clin Exp Immunol ; 156(3): 386-94, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19309349

ABSTRACT

Cardiovascular disease, in which atherosclerosis is the major underlying cause, is currently the largest cause of death in the world. Atherosclerosis is an inflammatory disease characterized by the formation of arterial lesions over a period of several decades at sites of endothelial cell dysfunction. These lesions are composed of endothelial cells, vascular smooth muscle cells, monocytes/macrophages and T lymphocytes (CD4(+)). As the lesions progress some can become unstable and prone to disruption, resulting in thrombus formation and possibly a myocardial infarction or stroke depending upon the location. Although the exact triggers for plaque disruption remain unknown, much recent evidence has shown a link between the incidence of myocardial infarction and stroke and a recent respiratory tract infection. Interestingly, many reports have also shown a link between a family of pattern recognition receptors, the Toll-like receptors, and the progression of atherosclerosis, suggesting that infections may play a role in both the progression of atherosclerosis and in inducing the more severe complications associated with the disease.


Subject(s)
Atherosclerosis/complications , Infections/complications , Toll-Like Receptors/immunology , Atherosclerosis/immunology , Cytokines/physiology , Humans , Infections/immunology , Inflammation Mediators/physiology , Lipids/physiology , Myocardial Infarction/etiology , Myocardial Infarction/immunology , Stroke/etiology
12.
Postgrad Med J ; 84(991): 259-64, 2008 May.
Article in English | MEDLINE | ID: mdl-18508983

ABSTRACT

Developing new treatments for chronic obstructive pulmonary disease (COPD) is extremely challenging. This disease, chronic by definition, becomes apparent only after substantial--and probably irreversible--tissue damage has occurred. The observable phenotype is of a stable disease state whose progression is hard to influence and reversal of which appears almost impossible. Identifying key components of the pathological process, targeting of which will result in substantial clinical benefit, is a significant challenge. In this review the nature of the disease is examined and conceptual information and simple tissue models of inflammation are used to explore the pathological network that is COPD. From the concept of COPD as a disease network displaying the features of contiguous immunity (in which many processes of innate and adaptive immunity are in continual dialogue and evolution), refinements are suggested to the strategies aimed at developing effective new treatments for this disease.

13.
Clin Exp Immunol ; 152(3): 440-7, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18422729

ABSTRACT

CCR6 is expressed by multiple leucocyte subsets, including peripheral blood memory T cells, and mouse models implicate a role for this receptor in diverse inflammatory responses that include allergic airway disorders, inflammatory bowel disease and autoimmune encephalitis. In order to study the role of CCR6 in humans, we have investigated the patterns of CCR6 expression and function on T cells from the peripheral blood, skin, nose and lung, in health and in allergic disease. Results show that CCR6 was expressed consistently on a higher proportion of tissue versus peripheral blood-derived CD4+ T cells (P < 0.01). CCR6 was expressed predominantly on CD4+ compared with CD8+ cells in both blood- and tissue-derived T cells (P < 0.001). The number of cells showing CCR6 expression was not proportionally greater in peripheral blood or nasal mucosal T cells of subjects with symptomatic allergic rhinitis. CCR6+ cells demonstrated enhanced functional responses to CCL20 and CCL20 was increased in bronchoalveolar lavage fluid of asthmatics following endobronchial allergen provocation (P < 0.05). Thus, CCR6 may be important in the regulation of T cell recruitment to tissue and up-regulation of CCL20 expression may contribute to the recruitment and/or retention of effector T cells in allergic asthma.


Subject(s)
Asthma/immunology , CD4-Positive T-Lymphocytes/immunology , Chemokine CCL20/metabolism , Receptors, CCR6/metabolism , T-Lymphocyte Subsets/immunology , Adult , Allergens/immunology , Bronchi/immunology , Bronchoalveolar Lavage Fluid/immunology , CD8-Positive T-Lymphocytes/immunology , Cells, Cultured , Chemokine CCL20/immunology , Chemotaxis, Leukocyte , Female , Humans , Male , Nasal Mucosa/immunology , Skin/immunology
14.
J Pathol ; 214(2): 126-35, 2008 Jan.
Article in English | MEDLINE | ID: mdl-18161748

ABSTRACT

The Toll-like receptor family was originally identified in Drosophila, where it provides important developmental and immunological signalling. In mammals, the developmental signal appears to have been lost, but the immunological defence role of these receptors has been expanded to provide broad recognition of bacterial, fungal, viral and parasitic pathogens. There is increasing evidence that these receptors go beyond the recognition of microbial molecules to sense host tissue damage. Recognition of host molecules and commensal microbes is also involved in the restoration of normal tissue architecture after injury and in maintenance of epithelial health. Recent developments in the TLR field highlight the importance of these molecules to human health and disease and demonstrate that their targeting, to boost immunity or inhibit inflammation, is both feasible and also potentially challenging.


Subject(s)
Inflammation/immunology , Toll-Like Receptors/immunology , Animals , Communicable Diseases/immunology , Humans , Ligands , Signal Transduction/immunology , Species Specificity
15.
Biochem Soc Trans ; 35(Pt 6): 1492-5, 2007 Dec.
Article in English | MEDLINE | ID: mdl-18031251

ABSTRACT

The neutrophil is a crucial early defence against microbial infection, but neutrophilic inflammation can result in devastating acute and chronic inflammatory diseases. In the lungs, the neutrophil is a principal part of the pathology of the acute respiratory distress syndrome, and its activation may also be of substantial importance in chronic obstructive pulmonary disease and some forms of asthma. Induction of neutrophil recruitment in response to microbial attack requires activation of TLR (Toll-like receptor)-based signalling pathways and the concerted actions of multiple cell types, including sentinel cells such as monocytes and macrophages acting together with tissue cell types such as the epithelium or smooth-muscle cell. The present review describes some of these networks and the resulting potential for their targeting in respiratory disease.


Subject(s)
Neutrophil Infiltration/immunology , Neutrophils/immunology , Respiratory Tract Infections/immunology , Toll-Like Receptors/immunology , Animals , Humans , Inflammation , Signal Transduction/immunology
16.
Clin Exp Immunol ; 147(2): 199-207, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17223959

ABSTRACT

The Toll-like receptor (TLR) family provide key components of mammalian immunity and are part of the earliest surveillance mechanisms responding to infection. Their activation triggers the innate immune response, and is crucial to the successful induction of Th1/Th2-phenotyped adaptive immunity. Innate immunity was long considered to be non-specific and somewhat simple compared to adaptive immunity, mediated via the engulfment and lysis of microbial pathogens by phagocytic cells such as macrophages and neutrophils, and involving no complex protein-protein interactions. The emergence of the TLR field has contributed to a revision of our understanding, and innate immunity is now viewed as a highly complex process, in line with adaptive immunity. This review will give a brief overview of our current knowledge of TLR biology, and will focus on TLRs as key components in complex networks that activate, integrate and select the appropriate innate and adaptive immune responses in the face of immunological danger.


Subject(s)
Toll-Like Receptors/immunology , Animals , Immunity, Cellular , Immunity, Innate , Inflammation/immunology , Signal Transduction/immunology
17.
Allergy ; 62(1): 59-65, 2007 Jan.
Article in English | MEDLINE | ID: mdl-17156343

ABSTRACT

BACKGROUND: In T cell-associated allergic inflammation, homing of T-helper 2 (Th2) effector cells to mucosal sites may be influenced by chemokine receptor expression. Previous studies have identified CCR3 and CCR4 as putative markers of Th2 cells and CCR5 and CXCR3 as markers of Th1 cells. The aim of this study was to assess differential chemokine receptor expression from symptomatic atopic grass pollen-sensitive subjects, compared with patients on high-dose allergen injection immunotherapy (IT) and healthy controls. METHODS: We examined chemokine receptor expression (CCR1-7 and CXCR1-4) by flow cytometry of peripheral blood CD4+ and CD8+ T cells. We also depleted peripheral blood mononuclear cell (PBMC) populations of CCR3+ CD4+ cells by magnetic bead separation and cells were stimulated with grass pollen allergen for 6 days. Cytokine production was measured by enzyme-linked immunosorbent assay. RESULTS: On freshly isolated PBMC, atopic individuals exhibited increased numbers of CCR3+ CD4+ cells compared with normal controls (P < 0.01). CCR3 expression in IT patients was reduced compared with matched atopic rhinitic controls (P < 0.05) and comparable with that observed in normal subjects. Depletion of CCR3+ CD4+ cells from allergen-stimulated PBMC cultures resulted in decreased interleukin (IL)-5 production compared with whole CD4+ populations (P < 0.05). Freshly isolated CCR3+ CD4+ cells have significantly higher intracellular IL-4 and lower IFN-gamma levels than CCR3- CD4+ cells. CD4+ T cells cultured from both peripheral cells and nasal biopsies demonstrated increased expression of CCR3 in the presence of IL-4 (P < 0.05). CONCLUSION: CCR3+ CD4+ T cells are increased in allergic rhinitis, are reduced by allergen IT, have a Th2 phenotype and contribute to allergen-specific responses. Strategies against CCR3+ T cells may be effective in human allergic diseases.


Subject(s)
Desensitization, Immunologic , Receptors, Chemokine/metabolism , Rhinitis, Allergic, Perennial/immunology , Rhinitis, Allergic, Perennial/metabolism , T-Lymphocytes/cytology , T-Lymphocytes/metabolism , Adult , Cell Count , Cells, Cultured , Female , Humans , Interleukin-5/metabolism , Leukocytes/metabolism , Male , Middle Aged , Poaceae/immunology , Receptors, CCR3 , Rhinitis, Allergic, Seasonal/immunology , Rhinitis, Allergic, Seasonal/metabolism , Th2 Cells/metabolism
18.
Biochem Soc Trans ; 32(Pt3): 456-60, 2004 Jun.
Article in English | MEDLINE | ID: mdl-15157159

ABSTRACT

Granulocyte apoptosis has been proposed as a fundamental, injury-limiting granulocyte-clearance mechanism. As such, inhibition of this process may prevent the resolution of inflammation. Our previous studies have shown that TNFalpha (tumour necrosis factor-alpha) has a bi-modal influence on the rate of constitutive neutrophil apoptosis in vitro, causing early acceleration and late inhibition of this process. The pro-apoptotic effect is uniquely TNFR1 (TNF receptor 1) and TNFR2-dependent and the latter survival process is mediated via phosphoinositide 3-kinase and NF-kappaB (nuclear factor-kappaB) activation. In the present study, we show that, in contrast with GM-CSF (granulocyte/macrophage colony-stimulating factor), the delayed addition (i.e. at 6 h) of TNFalpha increases its survival effect despite substantial loss of neutrophil TNFR1 and TNFR2 at that time. This paradox was resolved using PBMC (peripheral blood mononuclear cell)-deplete and 5% PBMC-replete neutrophil cultures, where the enhanced survival effect observed after delayed TNFalpha addition was shown to be PBMC-dependent. TNFR2-blocking antibodies had no effect on the late survival effect of TNFalpha, implying a TNFR1-dependent process. Finally, I-kappaBalpha (inhibitory kappaB-alpha) and NF-kappaB time-course studies demonstrated that the survival effects of both GM-CSF and TNFalpha could be explained by maintenance of functional NF-kappaB.


Subject(s)
Neutrophils/cytology , Tumor Necrosis Factor-alpha/physiology , Apoptosis , Blotting, Western , Cell Survival , Cells, Cultured , Granulocyte-Macrophage Colony-Stimulating Factor/metabolism , Humans , I-kappa B Proteins/metabolism , Leukocytes, Mononuclear/metabolism , Models, Biological , NF-KappaB Inhibitor alpha , NF-kappa B/metabolism , Neutrophils/metabolism , Neutrophils/pathology , Receptors, Tumor Necrosis Factor, Type II/metabolism , Signal Transduction , Time Factors , Tumor Necrosis Factor-alpha/metabolism
19.
Biochem Soc Trans ; 32(Pt3): 468-9, 2004 Jun.
Article in English | MEDLINE | ID: mdl-15157162

ABSTRACT

Neutrophil purification has traditionally been performed by centrifugation of leucocytes through density gradients. These reliable methods produce populations that are typically >95% pure neutrophils, and have allowed the widespread study of the function of these cells. Our recent work has suggested that residual monocytes may play a more important role than has been previously realized, and suggest that for some functional experiments, further purification of cells is required to understand fully the neutrophil phenotype.


Subject(s)
Neutrophils/cytology , Animals , Apoptosis , Cell Separation , Humans , Leukocytes, Mononuclear/metabolism , Lipopolysaccharides/metabolism , Monocytes/metabolism , Neutrophils/metabolism , Neutrophils/physiology , Phenotype , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...